FeesSafety
Pluang+

BTQ completes milestone validating QCIM chip for post-quantum cryptography in demanding conditions

Market News
07 Aug 2026
PRNewsWire
View Source
Bullish
BTQ completes milestone validating QCIM chip for post-quantum cryptography in demanding conditions

BTQ Technologies, in collaboration with ITRI and ICTK, has successfully completed the first milestone validating its Quantum Compute-in-Memory (QCIM) architecture for accelerating post-quantum cryptography standards FIPS 203, 204, and 205. This achievement confirms QCIM's ability to efficiently perform cryptographic operations in challenging environments, supporting future integration in military, industrial, automotive, IoT, and AI systems. The next phase will focus on module-level integration and verification, advancing QCIM toward commercial use with planned test chip shipments to key customers by year-end. This progress strengthens BTQ's position in developing secure, low-power cryptographic hardware for the quantum era.

More News

Canada's Royal Canadian Legion launches 2026 Poppy Campaign with new contactless donations and a commemorative mural.

Canada's Royal Canadian Legion launches 2026 Poppy Campaign with new contactless donations and a commemorative mural.

The Royal Canadian Legion has launched its 2026 National Poppy Campaign introducing a new contactless donation method using smartphones, supported by BMO and Toucan Giving technology. This innovation allows volunteers to collect donations via debit, ...

Others
Bullish
2 hours ago
XBiotech appoints Sushma Shivaswamy and Jan-Paul Simard as co-CEOs to lead antibody therapy development.

XBiotech appoints Sushma Shivaswamy and Jan-Paul Simard as co-CEOs to lead antibody therapy development.

XBiotech Inc. announced the appointment of Sushma Shivaswamy and Jan-Paul Simard as co-chief executive officers, effective October 23, 2026. Shivaswamy, with 17 years at the company, has led scientific operations and was interim CEO since December 20...

Market News
Bullish
3 hours ago
XBiotech appoints Jan-Paul Simard as Co-CEO alongside Sushma Shivaswamy to strengthen leadership.

XBiotech appoints Jan-Paul Simard as Co-CEO alongside Sushma Shivaswamy to strengthen leadership.

XBiotech Inc. announced the election of Jan-Paul Simard as Co-Chief Executive Officer alongside current CEO Dr. Sushma Shivaswamy, effective October 23, 2026. This leadership change aims to leverage their complementary skills and scientific expertise...

Market News
Bullish
3 hours ago
Bitdeer mined 283.4 BTC in a week and sold all, holding zero Bitcoin excluding customer deposits.

Bitdeer mined 283.4 BTC in a week and sold all, holding zero Bitcoin excluding customer deposits.

Bitdeer reported mining 283.4 Bitcoin in the week ending October 23 and sold the entire amount. Their weekly update showed no net Bitcoin additions and zero holdings after excluding customer deposits. This follows a similar report from the previous w...

Protocol Fundamentals
Neutral
4 hours ago
Ether long position linked to 黄立成 suffers $21K loss, total losses hit $35.35M with high leverage risks.

Ether long position linked to 黄立成 suffers $21K loss, total losses hit $35.35M with high leverage risks.

A leveraged long position of 315 Ether tied to 黄立成 showed a $21,000 unrealized loss, or 70%, as of October 24. The position used 25x leverage with an entry price of $2,447.57 and a liquidation price close at $2,336.90. Over the previous week, the add...

Technical Signals
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App